Mammographic densities as a criterion for entry to a clinical trial of breast cancer prevention.
about
Vision 20/20: Mammographic breast density and its clinical applicationsQuantitative assessment of percent breast density: analog versus digital acquisition.Chemoprevention of breast cancer: implications for postmenopausal women.Suitable trial designs and cohorts for preventive breast cancer agents.Feasibility of obtaining breast epithelial cells from healthy women for studies of cellular proliferation.
P2860
Mammographic densities as a criterion for entry to a clinical trial of breast cancer prevention.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Mammographic densities as a cr ...... l of breast cancer prevention.
@ast
Mammographic densities as a cr ...... l of breast cancer prevention.
@en
type
label
Mammographic densities as a cr ...... l of breast cancer prevention.
@ast
Mammographic densities as a cr ...... l of breast cancer prevention.
@en
prefLabel
Mammographic densities as a cr ...... l of breast cancer prevention.
@ast
Mammographic densities as a cr ...... l of breast cancer prevention.
@en
P2093
P2860
P356
P1476
Mammographic densities as a cr ...... l of breast cancer prevention.
@en
P2093
Lockwood G
MacDonald JC
Sparrow RK
Tritchler D
P2860
P2888
P304
P356
10.1038/BJC.1995.358
P407
P577
1995-08-01T00:00:00Z